First Manhattan’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.53M | Sell |
15,458
-2,859
| -16% | -$940K | 0.01% | 253 |
|
|
2025
Q4 | $6.42M | Buy |
18,317
+14,205
| +345% | +$4.8M | 0.02% | 207 |
|
|
2025
Q3 | $1.33M | Sell |
4,112
-215
| -5% | -$66.9K | ﹤0.01% | 389 |
|
|
2025
Q2 | $1.68M | Hold |
4,327
| – | – | ﹤0.01% | 348 |
|
|
2025
Q1 | $1.88M | Sell |
4,327
-385
| -8% | -$155K | 0.01% | 315 |
|
|
2024
Q4 | $1.74M | Buy |
4,712
+3,514
| +293% | +$1.47M | 0.01% | 320 |
|
|
2024
Q3 | $623K | Buy |
1,198
+19
| +2% | +$10.2K | ﹤0.01% | 445 |
|
|
2024
Q2 | $639K | Buy |
1,179
+692
| +142% | +$366K | ﹤0.01% | 424 |
|
|
2024
Q1 | $253K | Buy |
487
+31
| +7% | +$15.4K | ﹤0.01% | 618 |
|
|
2023
Q4 | $215K | Sell |
456
-4
| -0.9% | -$1.85K | ﹤0.01% | 637 |
|
|
2023
Q3 | $200K | Sell |
460
-23
| -5% | -$10.4K | ﹤0.01% | 657 |
|
|
2023
Q2 | $215K | Sell |
483
-9
| -2% | -$4.15K | ﹤0.01% | 649 |
|
|
2023
Q1 | $226K | Buy |
492
+34
| +7% | +$16.2K | ﹤0.01% | 655 |
|
|
2022
Q4 | $235K | Buy |
458
+102
| +29% | +$51.8K | ﹤0.01% | 661 |
|
|
2022
Q3 | $161K | Hold |
356
| – | – | ﹤0.01% | 728 |
|
|
2022
Q2 | $171K | Hold |
356
| – | – | ﹤0.01% | 745 |
|
|
2022
Q1 | $174K | Sell |
356
-100
| -22% | -$45.7K | ﹤0.01% | 784 |
|
|
2021
Q4 | $211K | Hold |
456
| – | – | ﹤0.01% | 728 |
|
|
2021
Q3 | $169K | Sell |
456
-470
| -51% | -$179K | ﹤0.01% | 767 |
|
|
2021
Q2 | $353K | Buy |
926
+150
| +19% | +$57.3K | ﹤0.01% | 626 |
|
|
2021
Q1 | $278K | Sell |
776
-94
| -11% | -$30.2K | ﹤0.01% | 645 |
|
|
2020
Q4 | $279K | Buy |
870
+265
| +44% | +$81.3K | ﹤0.01% | 602 |
|
|
2020
Q3 | $162K | Hold |
605
| – | – | ﹤0.01% | 686 |
|
|
2020
Q2 | $159K | Sell |
605
-80,000
| -99% | -$21.3M | ﹤0.01% | 690 |
|
|
2020
Q1 | $18.3M | Buy |
80,605
+80,094
| +15,674% | +$21.8M | 0.12% | 95 |
|
|
2019
Q4 | $154K | Sell |
511
-38
| -7% | -$10.5K | ﹤0.01% | 728 |
|
|
2019
Q3 | $131K | Buy |
549
+72
| +15% | +$19.7K | ﹤0.01% | 762 |
|
|
2019
Q2 | $134K | Hold |
477
| – | – | ﹤0.01% | 775 |
|
|
2019
Q1 | $136K | Buy |
477
+77
| +19% | +$22.3K | ﹤0.01% | 775 |
|
|
2018
Q4 | $105K | Hold |
400
| – | – | ﹤0.01% | 793 |
|
|
2018
Q3 | $109K | Hold |
400
| – | – | ﹤0.01% | 829 |
|
|
2018
Q2 | $95K | Hold |
400
| – | – | ﹤0.01% | 824 |
|
|
2018
Q1 | $87K | Sell |
400
-21
| -5% | -$4.93K | ﹤0.01% | 833 |
|
|
2017
Q4 | $94K | Buy |
421
+21
| +5% | +$4.47K | ﹤0.01% | 864 |
|
|
2017
Q3 | $75K | Hold |
400
| – | – | ﹤0.01% | 864 |
|
|
2017
Q2 | $75K | Hold |
400
| – | – | ﹤0.01% | 855 |
|
|
2017
Q1 | $66K | Hold |
400
| – | – | ﹤0.01% | 886 |
|
|
2016
Q4 | $57K | Sell |
400
-275
| -41% | -$36.8K | ﹤0.01% | 895 |
|
|
2016
Q3 | $84K | Hold |
675
| – | – | ﹤0.01% | 833 |
|
|
2016
Q2 | $88K | Hold |
675
| – | – | ﹤0.01% | 840 |
|
|
2016
Q1 | $93K | Sell |
675
-50
| -7% | -$6.68K | ﹤0.01% | 800 |
|
|
2015
Q4 | $101K | Hold |
725
| – | – | ﹤0.01% | 813 |
|
|
2015
Q3 | $101K | Hold |
725
| – | – | ﹤0.01% | 801 |
|
|
2015
Q2 | $119K | Hold |
725
| – | – | ﹤0.01% | 788 |
|
|
2015
Q1 | $111K | Sell |
725
-19
| -3% | -$2.71K | ﹤0.01% | 804 |
|
|
2014
Q4 | $93K | Hold |
744
| – | – | ﹤0.01% | 852 |
|
|
2014
Q3 | $88K | Sell |
744
-405
| -35% | -$46.5K | ﹤0.01% | 848 |
|
|
2014
Q2 | $123K | Buy |
1,149
+50
| +5% | +$5.15K | ﹤0.01% | 777 |
|
|
2014
Q1 | $109K | Sell |
1,099
-40
| -4% | -$3.62K | ﹤0.01% | 783 |
|
|
2013
Q4 | $105K | Hold |
1,139
| – | – | ﹤0.01% | 790 |
|
|
2013
Q3 | $95K | Hold |
1,139
| – | – | ﹤0.01% | 794 |
|
|
2013
Q2 | $97K | Buy |
+1,139
| New | +$85.2K | ﹤0.01% | 790 |
|
Other funds holding ELV
VCM
VPM
First Manhattan's ELV Position: Q1 2026 in Review
First Manhattan reduced its Elevance Health (ELV) stake by 16% in Q1 2026, selling an estimated $940K and leaving 15,458 shares worth $4.53M. The position accounts for 0.01% of the portfolio, ranked #253.
First Manhattan first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.3M in Q1 2020. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- First Manhattan held 15,458 shares of Elevance Health worth $4.53M as of Q1 2026.
- First Manhattan sold 2,859 Elevance Health shares in Q1 2026, an estimated $940K.
- Elevance Health made up 0.01% of First Manhattan's portfolio in Q1 2026, its #253 holding.
- First Manhattan first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- First Manhattan's Elevance Health position peaked at $18.3M in Q1 2020.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.